SCHEMBL2237608

SCHEMBL2237608

O=[N+]([O-])c1cccc(-c2ccncc2)c1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 5/20 0.49
ALDH1A1 P00352 2/20 0.49
PKN1 Q16512 1/20 0.48
PKN2 Q16513 1/20 0.48
CDC7 O00311 1/20 0.44
PDE7A Q13946 2/20 0.43
S100A4 P26447 2/20 0.43
PDE4B Q07343 1/20 0.43
PDE4D Q08499 1/20 0.43
PDE7B Q9NP56 1/20 0.43
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
RAB9A P51151 1/20 0.43
AURKA O14965 1/20 0.43
GSK3A P49840 1/20 0.43
GSK3B P49841 1/20 0.43
MAPT P10636 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10936303 0.84 ALDH1A1 (0.69) TDP1ALDH1A1S100A4MEN1KMT2A
SCHEMBL2235025 0.82 ALDH1A1 (0.71) TDP1ALDH1A1PKN1PKN2CDC7
Hydrochloric Acid SCHEMBL6608463 0.81 ALDH1A1 (0.69) TDP1ALDH1A1PKN1PKN2CDC7
SCHEMBL27775375 0.80 TDP1 (0.58) TDP1ALDH1A1PKN1PKN2CDC7
SCHEMBL15365347 0.80 TDP1 (0.49) TDP1ALDH1A1PKN1PKN2CDC7
SCHEMBL15875693 0.79 ALDH1A1 (0.67) TDP1ALDH1A1PKN1PKN2CDC7
SCHEMBL15875692 0.79 ALDH1A1 (0.61) TDP1ALDH1A1PKN1PKN2CDC7
SCHEMBL14956543 0.79 TDP1 (0.47) TDP1ALDH1A1S100A4MEN1KMT2A
SCHEMBL20997818 0.78 MAPT (0.48) ALDH1A1RAB9AMAPTHTTSMN1; SMN2
SCHEMBL1460867 0.75 TDP1 (0.61) TDP1ALDH1A1S100A4KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110201599-A1 CDK Modulators EXELIXIS, INC. (US) 2011-08-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110201599-A1 CDK Modulators CDK3, CDK1, CDKL1 TDP1 706/4885ALDH1A1 2581/4885PKN1 622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.